Theravance Biopharma (TBPH) Deferred Taxes (2024 - 2026)
Theravance Biopharma's (TBPH) quarterly Deferred Taxes came in at -$3.0 million in Q1 2026, down 61.93% year-on-year from -$7.9 million in Q1 2025, and down 10096.67% on a QoQ basis from $30000.0 in Q4 2025.
Theravance Biopharma (TBPH) Deferred Taxes (2024 - 2026) Analysis & Trends
Theravance Biopharma (TBPH) has 3 years of Deferred Taxes data on file, last reported at -$3.0 million in Q1 2026.
- On a quarterly basis, Deferred Taxes fell 61.93% year-over-year to -$3.0 million in Q1 2026; TTM through Mar 2026 was -$12.7 million, a 42.12% decrease from a year earlier, with the FY2025 full-year figure at -$11.5 million, down 52.11% from the prior year.
- Deferred Taxes for Q1 2026 stood at -$3.0 million, down from $30000.0 in the prior quarter.
- Over the last five years, Deferred Taxes for TBPH reached as high as $994000.0 in Q3 2025 and fell as low as -$10.7 million in Q2 2025.
- Historically, Deferred Taxes has averaged -$2.5 million across 3 years, with a median of -$561000.0 in 2024.
- On a YoY basis, Deferred Taxes climbed as much as 1004.44% in 2025 and fell as far as 1805.7% in 2025.
- Year by year, Deferred Taxes stood at -$6.6 million in 2024, then surged by 100.46% to $30000.0 in 2025, then slumped by 10096.67% to -$3.0 million in 2026.
- Per Business Quant data, the three most recent Deferred Taxes figures were -$3.0 million in Q1 2026, $30000.0 in Q4 2025, and $994000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Theravance Biopharma | 864.56 Mn | 469.90 Mn | - | -3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.00 Mn |
| Dec 31, 2025 | 30,000.00 |
| Sep 30, 2025 | 994,000.00 |
| Jun 30, 2025 | -10.69 Mn |
| Mar 31, 2025 | -1.85 Mn |
| Dec 31, 2024 | -6.59 Mn |
| Sep 30, 2024 | 90,000.00 |
| Jun 30, 2024 | -561,000.00 |
| Mar 31, 2024 | -513,000.00 |